Clinical Trial of the Senza™ SCS System in the Treatment of Chronic Upper Limb and Neck Pain
CompletedNot applicableNCT02385201
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This is a prospective, multi-center feasibility study of effectiveness and safety of the Senza System in subjects with chronic, intractable pain of the upper limbs and/or neck. Data at follow-up visits will be compared to Baseline data collected at the beginning of the study.
Study details
- Official title
- Multi-Center, Prospective, Clinical Trial of the Senza™ Spinal Cord Stimulation (SCS) System in the Treatment of Chronic Upper Limb and Neck Pain
- Conditions
- Interventions
- Device: Senza
- Sponsor
- Nevro Corp
- Start date
- 2015-06
- Primary completion
- 2017-06
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Have been diagnosed with chronic, intractable pain of the upper limb and/or neck related to the cervical spine and/or neuropathic arm pain 2. Considering daily activity and rest, have average upper limb and/or neck pain intensity of ≥ 5 out of 10 cm on the Visual Analog Scale (VAS) at enrollment 3. Be an appropriate candidate for the surgical procedures required in this study based on the clinical judgment of the implanting physician 4. Be on stable pain medications, as determined by the Investigator, for at least 28 days prior to enrolling in this study and be willing to stay on those medications with no dose adjustments until activation of the permanently implanted SCS device 5. Be 18 years of age or older at the time of enrollment 6. Be willing and capable of giving informed consent 7. Be willing and able to comply with study-related requirements, procedures, and visits 8. Be capable of subjective evaluation, able to read and understand English-written questionnaires, and are able to read, understand and sign the written inform consent in English. 9. Have adequate cognitive ability to use a patient programmer and recharger as determined by the Investigator Exclusion Criteria: 1. Have a medical condition or pain in other area(s), not intended to be treated with SCS, that could interfere with study procedures, as determined by the Investigator 2. Have evidence of an active disruptive psychological or psychiatric disorder as determined by a psychologist 3. Have a current diagnosis of a progressive neurological disease as determined by the Investigator 4. Have a current diagnosis of a coagulation disorder, bleeding diathesis, progressive peripheral vascular disease or uncontrolled diabetes mellitus 5. Have a condition that the Investigator determines would significantly increase perioperative risk 6. Significant cervical stenosis 7. Any previous history of surgery on the posterior elements (laminectomy, posterior fusion) 8. Be benefitting within from an interventional procedure and/or surgery to treat upper limb pain (Subjects should be enrolled at least 30 days from last benefit) 9. Have an existing drug pump and/or another active implantable device such as a pacemaker 10. Have a condition currently requiring or likely to require the use of MRI or diathermy 11. Have metastatic malignant disease or active local malignant disease 12. Have a life expectancy of less than 1 year 13. Have an active systemic or local infection 14. Be pregna…
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02385201